查看完整行情页>>

|

货币单位:美元(USD)

NovaBay Pharmaceuticals, Inc. (nby)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Paul E. Freiman Paul E. Freiman is the founder of Third Age Pharma LLC, which was founded in 2009. He holds the title of President at Third Age Pharma LLC starting in 2010. Dr. Freiman is also the founder of Impressions Holdings LLC. Dr. Freiman's current job(s) include being the Chairman at NovaBay Pharmaceuticals, Inc. since 2002, a Non-Executive Director at Chronix Biomedical, Inc., and a Director at Phytos, Inc.Dr. Freiman's former job(s) include being the Chairman & Chief Executive Officer at Syntex Corp. from 1989 to 1995, the President & Chief Executive Officer at Neurobiological Technologies, Inc. from 1997 to 2009, the Co-Chief Executive Officer at Synaptogenix, Inc. in 2014, the Chairman at Penwest Pharmaceuticals Co. from 1997 to 2010, the Chairman at Neurotrope, Inc. from 2013 to 2016, and a Director at NeoPharm, Inc. from 2004 to 2011. He also held various chairman positions at Digital Gene Technologies, Inc., Pharmaceutical Research & Manufacturers of America, UCSF Foundation, United Way Silicon Valley, and Pharmaceutical Manufacturers Association of America. Additionally, Dr. Freiman served as a Director at Calypte Biomedical Corp. from 1997 to 2009, NovaCal Pharmaceuticals, Inc. from 2001 to 2002, SciGen Pte Ltd., OMware, Inc., Otsuka America, Inc., Otsuka America Pharmaceutical, Inc., InSys Therapeutics, Inc. from 2004 to 2011, and INSYS Therapeutics, Inc. in 2010. Dr. Freiman's education history includes undergraduate studies at Fordham University.
Justin M. Hall Justin M. Hall is currently the President, CEO, Director, and General Counsel at NovaBay Pharmaceuticals, Inc. He previously worked as the Corporate Counsel at Accuray, Inc. from 2006 to 2013. Mr. Hall completed his undergraduate degree at the University of California San Diego and his graduate degree at the University of San Diego School of Law.
Tommy Law Tommy Law is currently the Chief Financial Officer, Treasurer & Controller at NovaBay Pharmaceuticals, Inc. He previously worked as a Senior Accountant at KP Corp. (United States) from 2017 to 2019. Mr. Law completed his undergraduate degree at San Jose State University.
Yen You Zheng Yen You Zheng was the founder of Crestwell Resources, Inc. (2011) and Overseas Public, Inc. (2004), where he held the titles of Independent Director and Chairman & Chief Executive Officer, respectively. Currently, he holds positions as an Independent Director at NovaBay Pharmaceuticals, Inc. (2019-present), Director at Tri-River Ventures, Inc., Independent Director at MARS Acquisition Corp., Director of Business Development at Craft Capital Management LLC (2019-present), and Vice President at Canada-China Business Association. Dr. Zheng's former positions include Chief Executive Officer at Smooth Global (China) Holdings, Inc., President, Chief Executive Officer & Secretary at Goldstrike, Inc., President, CEO & Non-Independent Director at P&P Ventures, Inc., Director at Cantronic Systems, Inc., Director-Business Development at Spartan Securities Group Ltd., Chief Financial Officer & Director at Damon Capital Corp., and President at China Linen Textile Industry Ltd. He also served as a Senior Research Associate at the University of British Columbia and an Adjunct Professor at Tsinghua University. Dr. Zheng received a doctorate degree from Flinders University in 1990.
Swan Sit Swan Sit is an Independent Director at Edgewell Personal Care Co., NovaBay Pharmaceuticals, Inc., and Director at Far Niente Winery, Inc. She is also a Member-Advisory Board at AF Acquisition Corp. Previously, she worked as Executive Director-Strategy & Planning, Online at The Estée Lauder Companies, Inc. She was also Vice President-Global Digital Marketing at NIKE, Inc. and Vice President-Global Digital at Revlon, Inc. and Elizabeth Arden, Inc. Ms. Sit completed her undergraduate degree at Harvard University and earned an MBA from Columbia Business School.
Julie Garlikov Julie Garlikov is an Independent Director at NovaBay Pharmaceuticals, Inc., Vice President-Marketing at GRAIL LLC, and Chief Commercial Officer at Sherlock Biosciences, Inc. She was previously Vice President-Marketing at Nuvesse Skin Therapies, Inc., Vice President & Head-Global Brand Marketing at Rodan & Fields LLC, Chief Marketing Officer at Shaklee Corp., and Chief Marketing Officer at Partner Co. Garlikov holds an undergraduate degree from the University of California, Berkeley and an MBA from Columbia Business School.